← Back to headlines
Elutia Outlines Launch Timeline for NXT-41x in Breast Reconstruction Market
Elutia has detailed the launch timeline for its NXT-41x product, targeting the $1.5 billion breast reconstruction market, while also strengthening its leadership team.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
